StockMacro
Menu

Orthofix Medical

$6.07 -38% in 6 monthsMarket cap $247.4M

OFIX on XNAS, Health Care, Orthofix Medical Inc., job postings

Measures activity, not value. Not investment advice.

Shares fell 38% in one month and 58% in a year as insiders bought $5.1M in 90 days.

  • BadNet loss of $45M over 12 months despite revenue up 2.1%
  • WatchCapital spending up 46% to $14.5M last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
1,605
Website
orthofix.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 23 Feb 2027 (an estimate: a year ago it reported on 24 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $207.9M, net loss $6.1M.
Quarter to 31 Dec 2021: revenue $125.1M, net income -$32.8MQuarter to 31 Dec 2021: revenue $125.1M, net income -$32.8MQuarter to 31 Mar 2022: revenue $106.4M, net income -$4.5MQuarter to 31 Mar 2022: revenue $106.4M, net income -$4.5MQuarter to 30 Jun 2022: revenue $118.1M, net income $2.5MQuarter to 30 Jun 2022: revenue $118.1M, net income $2.5MQuarter to 30 Sep 2022: revenue $114.0M, net income -$10.7MQuarter to 30 Sep 2022: revenue $114.0M, net income -$10.7MQuarter to 31 Dec 2022: revenue $122.2M, net income -$7.1MQuarter to 31 Dec 2022: revenue $122.2M, net income -$7.1MQuarter to 31 Mar 2023: revenue $175.2M, net income -$60.9MQuarter to 31 Mar 2023: revenue $175.2M, net income -$60.9MQuarter to 30 Jun 2023: revenue $187.0M, net income -$39.4MQuarter to 30 Jun 2023: revenue $187.0M, net income -$39.4MQuarter to 30 Sep 2023: revenue $184.0M, net income -$28.9MQuarter to 30 Sep 2023: revenue $184.0M, net income -$28.9MQuarter to 31 Dec 2023: revenue $200.4M, net income -$22.2MQuarter to 31 Dec 2023: revenue $200.4M, net income -$22.2MQuarter to 31 Mar 2024: revenue $188.6M, net income -$36.0MQuarter to 31 Mar 2024: revenue $188.6M, net income -$36.0MQuarter to 30 Jun 2024: revenue $198.6M, net income -$33.4MQuarter to 30 Jun 2024: revenue $198.6M, net income -$33.4MQuarter to 30 Sep 2024: revenue $196.6M, net income -$27.4MQuarter to 30 Sep 2024: revenue $196.6M, net income -$27.4MQuarter to 31 Dec 2024: revenue $215.7M, net income -$29.1MQuarter to 31 Dec 2024: revenue $215.7M, net income -$29.1MQuarter to 31 Mar 2025: revenue $193.6M, net income -$53.1MQuarter to 31 Mar 2025: revenue $193.6M, net income -$53.1MQuarter to 30 Jun 2025: revenue $203.1M, net income -$14.1MQuarter to 30 Jun 2025: revenue $203.1M, net income -$14.1MQuarter to 30 Sep 2025: revenue $205.6M, net income -$22.8MQuarter to 30 Sep 2025: revenue $205.6M, net income -$22.8MQuarter to 31 Dec 2025: revenue $219.9M, net income -$2.2MQuarter to 31 Dec 2025: revenue $219.9M, net income -$2.2MQuarter to 31 Mar 2026: revenue $196.7M, net income -$20.9MQuarter to 31 Mar 2026: revenue $196.7M, net income -$20.9MQuarter to 30 Jun 2026: revenue $210.9M, net income -$15.8MQuarter to 30 Jun 2026: revenue $210.9M, net income -$15.8MQuarter to 30 Sep 2026: revenue $207.9M, net income -$6.1MQuarter to 30 Sep 2026: revenue $207.9M, net income -$6.1M
31 Dec 2021RevenueNet incomeNet losstallest bar $219.9M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$207.9M-$6.1M
30 Jun 2026$210.9M-$15.8M
31 Mar 2026$196.7M-$20.9M
31 Dec 2025$219.9M-$2.2M
30 Sep 2025$205.6M-$22.8M
30 Jun 2025$203.1M-$14.1M
31 Mar 2025$193.6M-$53.1M
31 Dec 2024$215.7M-$29.1M
30 Sep 2024$196.6M-$27.4M
30 Jun 2024$198.6M-$33.4M
31 Mar 2024$188.6M-$36.0M
31 Dec 2023$200.4M-$22.2M
30 Sep 2023$184.0M-$28.9M
30 Jun 2023$187.0M-$39.4M
31 Mar 2023$175.2M-$60.9M
31 Dec 2022$122.2M-$7.1M
30 Sep 2022$114.0M-$10.7M
30 Jun 2022$118.1M$2.5M
31 Mar 2022$106.4M-$4.5M
31 Dec 2021$125.1M-$32.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $835.4M $818.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +2.1% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$45.0M -$119.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.11 -$3.03
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 70.9% 68.3% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -2.5% -11.4% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -5.4% -14.6% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -10.3% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$44.5M -$2.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $86.3M $62.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $221.8M $157.2M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $135.5M $94.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.52 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $10.54
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.30 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.46 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.58 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Orthofix MedicalOFIX (this company) $247.4Mloss0.30+2.1%-5.4%
SS Innovations InternationalSSII $254.9Mloss5.5+27%-31.5%
OraSure TechnologiesOSUR $238.9Mloss2.1-7.5%-41.7%
Profound MedicalPROF $233.7Mloss9.9+65%-138%
NeuropaceNPCE $273.9Mloss2.9+8.9%-20.0%
ClearPoint NeuroCLPT $221.5Mloss4.9+33%-79.4%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

+$2.4M

bought $5.1M, sold $2.7M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-5.0%

133 13F filers vs 140

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

96%

39.3M shares held by 13F filers (30 Sep 2026) of 40.8M outstanding (5 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

5.3%

2.2M shares sold short (30 Oct 2026) of 40.8M outstanding (5 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.1

2.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-9.1%

2.4M shares sold short in the report before, 2.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

50%

50% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+1.1%

$207.9M vs $205.6M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+46%

$14.5M vs $9.9M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

17

17 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

17×

17 articles in the last 7 days; its usual week has 1.

Price $6.07 on 20 Nov 2026, -58% over 12 months (12-month range $6.07 to $16.20)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $2.6M in the last 12 months (the 12 months before: $959K).
Revenue per quarter. Revenue $207.9M in the latest quarter, +1.1% on a year earlier.
Capital spending per quarter. Capital spending $14.5M in the latest quarter, +46% on a year earlier.
Institutional holders (13F filers). 133 13F filers reported holding it in the latest 13F quarter, -1.5% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
11 Jun 20268-K and other filingsDirector or officer change
9 Apr 20268-K and other filingsDirector or officer change
9 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 May 2025Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.4M)
7 Apr 20258-K and other filingsA major agreement ended
12 Mar 20258-K and other filingsDirector or officer change
12 Mar 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Nov 20248-K and other filingsA major agreement ended
20 Jun 20248-K and other filingsDirector or officer change
12 Apr 20248-K and other filingsDirector or officer change
2 Apr 2024Sharp changeShort interest spike: short interest spike, 3.7M vs usual 1.2M (2024-03-15); 3.4x the same period a year earlier
12 Mar 2024Sharp changeQuarterly revenue change: quarterly revenue change, 200.4M vs usual 123.6M (2023-12-31); 1.6x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.1M (2024-02-29); 3.5x the same period a year earlier
12 Mar 2024Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 14.6M vs usual 6.0M (2023-12-31); 2.8x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.1M (2024-02-15); 3.3x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 2.7M vs usual 1.1M (2024-01-31); 2.8x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.1M (2024-01-12); 3.1x the same period a year earlier
17 Jan 20248-K and other filingsDirector or officer change
16 Jan 2024Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.0M (2023-12-29); 4.3x the same period a year earlier
9 Jan 20248-K and other filingsDirector or officer change
2 Jan 2024Sharp changeShort interest spike: short interest spike, 4.7M vs usual 1.0M (2023-12-15); 5.6x the same period a year earlier
15 Dec 20238-K and other filingsDirector or officer change
12 Dec 2023Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.0M (2023-11-30); 3.6x the same period a year earlier
1 Dec 20238-K and other filingsDirector or officer change
28 Nov 2023Sharp changeShort interest spike: short interest spike, 3.3M vs usual 1.0M (2023-11-15); 3.3x the same period a year earlier
14 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 184.0M vs usual 120.1M (2023-09-30); 1.6x the same period a year earlier
14 Nov 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 21.9M vs usual 5.5M (2023-09-30); 4.3x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 3.0M vs usual 1.0M (2023-10-31); 3.0x the same period a year earlier
8 Nov 20238-K and other filingsA major agreement ended
4 Oct 20238-K and other filingsDirector or officer change
3 Oct 20238-K and other filingsDirector or officer change
14 Sep 20238-K and other filingsDirector or officer change
15 Aug 2023Sharp changeQuarterly revenue change: quarterly revenue change, 187.0M vs usual 119.7M (2023-06-30); 1.6x the same period a year earlier
15 Aug 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 12.4M vs usual 5.3M (2023-06-30); 2.2x the same period a year earlier
21 Jun 20238-K and other filingsDirector or officer change
20 Jun 20238-K and other filingsDirector or officer change
16 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 175.2M vs usual 116.0M (2023-03-31); 1.6x the same period a year earlier
16 May 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 11.5M vs usual 5.2M (2023-03-31); 2.2x the same period a year earlier
7 Apr 20238-K and other filingsDirector or officer change
7 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Mar 2023Sharp changeShort interest spike: short interest spike, 1.0M vs usual 416K (2023-02-28); 3.5x the same period a year earlier
28 Feb 2023Sharp changeShort interest spike: short interest spike, 1.0M vs usual 407K (2023-02-15); 3.5x the same period a year earlier
14 Feb 2023Sharp changeShort interest spike: short interest spike, 986K vs usual 402K (2023-01-31); 3.7x the same period a year earlier
31 Jan 2023Sharp changeShort interest spike: short interest spike, 961K vs usual 398K (2023-01-13); 3.3x the same period a year earlier
5 Jan 20238-K and other filingsDirector or officer change
5 Jan 20238-K and other filingsCompleted an acquisition or asset sale
5 Jan 20238-K and other filingsA major agreement ended
5 Jan 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jan 2023Sharp changeShort interest spike: short interest spike, 841K vs usual 367K (2022-12-15); 2.9x the same period a year earlier
13 Dec 2022Sharp changeShort interest spike: short interest spike, 1.0M vs usual 344K (2022-11-30); 4.4x the same period a year earlier
29 Nov 2022Sharp changeShort interest spike: short interest spike, 1.0M vs usual 336K (2022-11-15); 5.0x the same period a year earlier
15 Nov 2022Sharp changeMany funds opening a new position: many funds opening a new position, 29 vs usual 12 (2022-09-30); 1.8x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 981K vs usual 326K (2022-10-31); 3.0x the same period a year earlier
1 Nov 2022Sharp changeShort interest spike: short interest spike, 619K vs usual 326K (2022-10-14); 1.9x the same period a year earlier
7 Jun 20228-K and other filingsDirector or officer change
8 Apr 20228-K and other filingsDirector or officer change
8 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Nov 2021: $62K published
Month from 1 Apr 2023: -$76K published
Month from 1 May 2023: -$157K published
Month from 1 Sep 2023: $101K published
Month from 1 Dec 2024: -$464 published
Month from 1 Jan 2025: -$427K published
Month from 1 Feb 2025: -$17K published
Month from 1 Mar 2025: $97K published
Month from 1 Apr 2025: -$52K published
Month from 1 May 2025: $1.4M published
Month from 1 Jun 2025: -$34K published
Month from 1 Jul 2025: $14K published
Month from 1 Aug 2025: -$28K published
Month from 1 Jan 2026: -$371K published
Month from 1 Feb 2026: $1.7M published
Month from 1 Mar 2026: -$349K published
Month from 1 Apr 2026: -$48K published
Month from 1 May 2026: -$295K published
Month from 1 Jun 2026: -$34K published
Month from 1 Aug 2026: -$416K published
Month from 1 Sep 2026: -$2.7M published
Month from 1 Oct 2026: -$1K published
Month from 1 Nov 2026: $5.1M published
Revenue per quarter
Quarter ended 31 Dec 2021: $125.1M, +6.3% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $106.4M, +0.8% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $118.1M, -2.7% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $114.0M, +1.4% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $122.2M, -2.3% on a year earlier; public on 7 Mar 2023
Quarter ended 31 Mar 2023: $175.2M, +65% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $187.0M, +58% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $184.0M, +61% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $200.4M, +64% on a year earlier; public on 6 Mar 2024
Quarter ended 31 Mar 2024: $188.6M, +7.7% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $198.6M, +6.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $196.6M, +6.8% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $215.7M, +7.6% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $193.6M, +2.7% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $203.1M, +2.3% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $205.6M, +4.6% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $219.9M, +2.0% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $196.7M, +1.6% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $210.9M, +3.8% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $207.9M, +1.1% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $6.2M, +61% on a year earlier; public on 26 Feb 2022
Quarter ended 31 Mar 2022: $5.3M, +22% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $5.7M, +22% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $5.1M, +103% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $5.2M, -16% on a year earlier; public on 7 Mar 2023
Quarter ended 31 Mar 2023: $11.5M, +115% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $12.4M, +117% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $21.9M, +327% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $14.6M, +180% on a year earlier; public on 6 Mar 2024
Quarter ended 31 Mar 2024: $10.5M, -8.1% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $9.3M, -24% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $5.3M, -76% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $8.5M, -41% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $6.7M, -36% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $7.1M, -24% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $9.9M, +86% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $10.9M, +27% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $10.7M, +58% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $12.6M, +78% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $14.5M, +46% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 121; public on 14 Feb 2022
31 Mar 2022 report: 139; public on 16 May 2022
30 Jun 2022 report: 122; public on 15 Aug 2022
30 Sep 2022 report: 131; public on 14 Nov 2022
31 Dec 2022 report: 141; public on 14 Feb 2023
31 Mar 2023 report: 150; public on 15 May 2023
30 Jun 2023 report: 134; public on 14 Aug 2023
30 Sep 2023 report: 146; public on 14 Nov 2023
31 Dec 2023 report: 146; public on 14 Feb 2024
31 Mar 2024 report: 130; public on 15 May 2024
30 Jun 2024 report: 126; public on 14 Aug 2024
30 Sep 2024 report: 145; public on 14 Nov 2024
31 Dec 2024 report: 147; public on 14 Feb 2025
31 Mar 2025 report: 152; public on 15 May 2025
30 Jun 2025 report: 152; public on 14 Aug 2025
30 Sep 2025 report: 135; public on 14 Nov 2025
31 Dec 2025 report: 137; public on 17 Feb 2026
31 Mar 2026 report: 141; public on 15 May 2026
30 Jun 2026 report: 140; public on 14 Aug 2026
30 Sep 2026 report: 133; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $5.1M (12 Nov 2026), higher than 100% of its own history.
  • Insider net buying (open market): Insiders bought a net $2.6M in the last 12 months (the 12 months before: $959K).
  • Revenue per quarter: Revenue $207.9M in the latest quarter, +1.1% on a year earlier.
  • Capital spending per quarter: Capital spending $14.5M in the latest quarter, +46% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 93 insider trades

Last 90 days: 4 sales, $2.7M; 1 purchase, $5.1M. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
12 Nov 2026Juniper Investment Company, LLC and 2 others10% ownerBuy689,803$7.40$5.1MForm 4
4 Nov 2026Patrick FisherPresident, Global Limb ReconSellplanned in advance (10b5-1)150$9.07$1KForm 4
5 Oct 2026Patrick FisherPresident, Global Limb ReconSellplanned in advance (10b5-1)150$9.44$1KForm 4
22 Sep 2026Juniper Investment Company, LLC and 2 others10% ownerSell310,000$8.81$2.7MForm 4
3 Sep 2026Patrick FisherPresident, Global Limb ReconSellplanned in advance (10b5-1)150$9.39$1KForm 4
20 Aug 2026Patrick FisherPresident, Global Limb ReconSell1,295$10.09$13KForm 4
18 Aug 2026Alexis P Michas and 2 others10% ownerSell39,500$10.19$403KForm 4
22 Jun 2026Aviva McPherronPres, Global Ops & QualSell3,670$9.38$34KForm 4

133 institutions reported shares at the end of Q3 2026, 96% of the shares outstanding; 15 opened a position, 21 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Juniper Investment Company, LLC4.8M11.8%$45.1M+350K+7.9%
Engine Capital Management, LP4.6M11.2%$43.1MNo change
BlackRock, Inc.3.9M9.48%$36.4M+537K+16%
Rubric Capital Management LP3.7M9.13%$35.0MNo change
Armistice Capital, LLC3.6M8.89%$34.1M+360K+11%
Paradigm Capital Management Inc3.3M8.08%$31.0M-6,600-0.2%
Vanguard Capital Management LLC1.7M4.18%$16.0M-28K-1.6%
State Street Corp1.0M2.46%$9.4M+48K+5.1%
Millennium Management LLC949K2.33%$8.9M+87K+10%
Geode Capital Management, LLC925K2.27%$8.7M-123K-12%

Company events

All 54 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
11 Jun 2026Director or officer changeSame filing: shareholder vote results8-K
9 Apr 2026Director or officer change8-K
7 Apr 2025Signed a major agreement; A major agreement ended8-K
12 Mar 2025Director or officer change8-K
8 Nov 2024Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
20 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
19 Apr 2024Signed a major agreement8-K
12 Apr 2024Director or officer change8-K

The 5 newest of 73 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Nov 2023confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Orthofix Medical (OFIX): spent $21.9M on capital projects in the quarter ended 30 Sep 2023, 4.3× the same quarter last year, while it had 4.7M shares sold short in the 15 Dec 2023 report, 5.6× the same report last year. Two unrelated kinds of activity within 140 days.

  • Financials: Quarterly capital spending jump, became public on 14 Nov 2023
  • Financials: Quarterly revenue change, became public on 14 Nov 2023
  • Short interest and volume: Short interest spike, became public on 10 Nov 2023
  • Short interest and volume: Short interest spike, became public on 28 Nov 2023
  • Short interest and volume: Short interest spike, became public on 12 Dec 2023
  • Short interest and volume: Short interest spike, became public on 28 Dec 2023
  • Short interest and volume: Short interest spike, became public on 11 Jan 2024
  • Short interest and volume: Short interest spike, became public on 25 Jan 2024
  • Short interest and volume: Short interest spike, became public on 10 Feb 2024
  • Short interest and volume: Short interest spike, became public on 28 Feb 2024
  • Financials: Quarterly capital spending jump, became public on 12 Mar 2024
  • Financials: Quarterly revenue change, became public on 12 Mar 2024
  • Short interest and volume: Short interest spike, became public on 12 Mar 2024
  • Short interest and volume: Short interest spike, became public on 27 Mar 2024
2021-09-30: $2.5M2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M
The quarter ended 30 Sep 2023 against the 8 quarters before it. this quarterearliernormal: $5.5M
See the evidence (14 changes)

Financials: Quarterly capital spending jump became public on 14 Nov 2023

Orthofix Medical spent $21.9M on capital projects in the quarter ended 30 Sep 2023, 4.3× the same quarter last year.

This period
$21.9M (the quarter ended 30 Sep 2023)
Normal quarter (median of 8 earlier)
$5.5M
Typical spread (median absolute deviation)
$549K
How far from its usual level
+16.4
Same quarter last year
$5.1M
History used
4,748 days
2021-09-30: $2.5M2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M
the quarter ended 30 Sep 20238 earlier quartersnormal: $5.5M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Financials: Quarterly revenue change became public on 14 Nov 2023

Orthofix Medical reported revenue of $184.0M for the quarter ended 30 Sep 2023, 1.6× the same quarter last year.

This period
$184.0M (the quarter ended 30 Sep 2023)
Normal quarter (median of 8 earlier)
$120.1M
Typical spread (median absolute deviation)
$6.9M
How far from its usual level
+5.3
Same quarter last year
$114.0M
History used
4,931 days
2021-09-30: $112.4M2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M
the quarter ended 30 Sep 20238 earlier quartersnormal: $120.1M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 10 Nov 2023

Orthofix Medical had 3.0M shares sold short in the 31 Oct 2023 report, 3.0× the same report last year.

This period
3.0M (the 31 Oct 2023 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
93K
How far from its usual level
+14.3
Same report last year
981K
History used
2,132 days
2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M
the 31 Oct 2023 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Nov 2023

Orthofix Medical had 3.3M shares sold short in the 15 Nov 2023 report, 3.3× the same report last year.

This period
3.3M (the 15 Nov 2023 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
131K
How far from its usual level
+12.0
Same report last year
1.0M
History used
2,147 days
2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M
the 15 Nov 2023 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Dec 2023

Orthofix Medical had 3.6M shares sold short in the 30 Nov 2023 report, 3.6× the same report last year.

This period
3.6M (the 30 Nov 2023 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
169K
How far from its usual level
+10.4
Same report last year
1.0M
History used
2,162 days
2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M
the 30 Nov 2023 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Dec 2023

Orthofix Medical had 4.7M shares sold short in the 15 Dec 2023 report, 5.6× the same report last year.

This period
4.7M (the 15 Dec 2023 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
177K
How far from its usual level
+14.1
Same report last year
841K
History used
2,177 days
2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M
the 15 Dec 2023 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 11 Jan 2024

Orthofix Medical had 2.9M shares sold short in the 29 Dec 2023 report, 4.3× the same report last year.

This period
2.9M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
196K
How far from its usual level
+6.4
Same report last year
670K
History used
2,191 days
2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M
the 29 Dec 2023 report24 earlier reportsnormal: 1.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Jan 2024

Orthofix Medical had 2.9M shares sold short in the 12 Jan 2024 report, 3.1× the same report last year.

This period
2.9M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
184K
How far from its usual level
+6.9
Same report last year
961K
History used
2,205 days
2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M
the 12 Jan 2024 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Feb 2024

Orthofix Medical had 2.7M shares sold short in the 31 Jan 2024 report, 2.8× the same report last year.

This period
2.7M (the 31 Jan 2024 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
238K
How far from its usual level
+4.6
Same report last year
986K
History used
2,224 days
2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M
the 31 Jan 2024 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Feb 2024

Orthofix Medical had 3.3M shares sold short in the 15 Feb 2024 report, 3.3× the same report last year.

This period
3.3M (the 15 Feb 2024 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
331K
How far from its usual level
+4.5
Same report last year
1.0M
History used
2,239 days
2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M
the 15 Feb 2024 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly capital spending jump became public on 12 Mar 2024

Orthofix Medical spent $14.6M on capital projects in the quarter ended 31 Dec 2023, 2.8× the same quarter last year.

This period
$14.6M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$6.0M
Typical spread (median absolute deviation)
$798K
How far from its usual level
+7.3
Same quarter last year
$5.2M
History used
4,840 days
2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M2023-12-31: $14.6M
the quarter ended 31 Dec 20238 earlier quartersnormal: $6.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Financials: Quarterly revenue change became public on 12 Mar 2024

Orthofix Medical reported revenue of $200.4M for the quarter ended 31 Dec 2023, 1.6× the same quarter last year.

This period
$200.4M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$123.6M
Typical spread (median absolute deviation)
$13.4M
How far from its usual level
+3.9
Same quarter last year
$122.2M
History used
5,023 days
2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M2023-12-31: $200.4M
the quarter ended 31 Dec 20238 earlier quartersnormal: $123.6M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 12 Mar 2024

Orthofix Medical had 3.6M shares sold short in the 29 Feb 2024 report, 3.5× the same report last year.

This period
3.6M (the 29 Feb 2024 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
381K
How far from its usual level
+4.3
Same report last year
1.0M
History used
2,253 days
2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M
the 29 Feb 2024 report24 earlier reportsnormal: 1.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 27 Mar 2024

Orthofix Medical had 3.7M shares sold short in the 15 Mar 2024 report, 3.4× the same report last year.

This period
3.7M (the 15 Mar 2024 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
461K
How far from its usual level
+3.7
Same report last year
1.1M
History used
2,268 days
2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M2024-03-15: 3.7M
the 15 Mar 2024 report24 earlier reportsnormal: 1.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

15 Nov 2022confirmed

Confirmed across sources Institutional holdings and Short interest and volume

Orthofix Medical (OFIX): saw 29 13F filers open a new position in the quarter ended 30 Sep 2022, 1.8× the same quarter last year, while it had 981K shares sold short in the 31 Oct 2022 report, 3.0× the same report last year. Two unrelated kinds of activity within 133 days.

  • Short interest and volume: Short interest spike, became public on 26 Oct 2022
  • Institutional holdings: Many funds opening a new position, became public on 14 Nov 2022
  • Short interest and volume: Short interest spike, became public on 10 Nov 2022
  • Short interest and volume: Short interest spike, became public on 26 Nov 2022
  • Short interest and volume: Short interest spike, became public on 10 Dec 2022
  • Short interest and volume: Short interest spike, became public on 28 Dec 2022
  • Short interest and volume: Short interest spike, became public on 26 Jan 2023
  • Short interest and volume: Short interest spike, became public on 10 Feb 2023
  • Short interest and volume: Short interest spike, became public on 28 Feb 2023
  • Short interest and volume: Short interest spike, became public on 10 Mar 2023
2020-09-30: 72020-12-31: 132021-03-31: 152021-06-30: 112021-09-30: 162021-12-31: 102022-03-31: 202022-06-30: 112022-09-30: 29
The quarter ended 30 Sep 2022 against the 8 quarters before it. this quarterearliernormal: 12
See the evidence (10 changes)

Short interest and volume: Short interest spike became public on 26 Oct 2022

Orthofix Medical had 619K shares sold short in the 14 Oct 2022 report, 1.9× the same report last year.

This period
619K (the 14 Oct 2022 report)
Normal report (median of 24 earlier)
326K
Typical spread (median absolute deviation)
51K
How far from its usual level
+3.9
Same report last year
319K
History used
1,750 days
2021-09-30: 412K2021-10-15: 319K2021-10-29: 328K2021-11-15: 199K2021-11-30: 232K2021-12-15: 285K2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K
the 14 Oct 2022 report24 earlier reportsnormal: 326K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Institutional holdings: Many funds opening a new position became public on 14 Nov 2022

Orthofix Medical saw 29 13F filers open a new position in the quarter ended 30 Sep 2022, 1.8× the same quarter last year.

This period
29 (the quarter ended 30 Sep 2022)
Normal quarter (median of 8 earlier)
12
Typical spread (median absolute deviation)
2.5
How far from its usual level
+4.6
Same quarter last year
16
History used
3,287 days
2020-09-30: 72020-12-31: 132021-03-31: 152021-06-30: 112021-09-30: 162021-12-31: 102022-03-31: 202022-06-30: 112022-09-30: 29
the quarter ended 30 Sep 20228 earlier quartersnormal: 12

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Short interest and volume: Short interest spike became public on 10 Nov 2022

Orthofix Medical had 981K shares sold short in the 31 Oct 2022 report, 3.0× the same report last year.

This period
981K (the 31 Oct 2022 report)
Normal report (median of 24 earlier)
326K
Typical spread (median absolute deviation)
51K
How far from its usual level
+8.6
Same report last year
328K
History used
1,767 days
2021-10-15: 319K2021-10-29: 328K2021-11-15: 199K2021-11-30: 232K2021-12-15: 285K2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K
the 31 Oct 2022 report24 earlier reportsnormal: 326K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Nov 2022

Orthofix Medical had 1.0M shares sold short in the 15 Nov 2022 report, 5.0× the same report last year.

This period
1.0M (the 15 Nov 2022 report)
Normal report (median of 24 earlier)
336K
Typical spread (median absolute deviation)
58K
How far from its usual level
+7.8
Same report last year
199K
History used
1,782 days
2021-10-29: 328K2021-11-15: 199K2021-11-30: 232K2021-12-15: 285K2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M
the 15 Nov 2022 report24 earlier reportsnormal: 336K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Dec 2022

Orthofix Medical had 1.0M shares sold short in the 30 Nov 2022 report, 4.4× the same report last year.

This period
1.0M (the 30 Nov 2022 report)
Normal report (median of 24 earlier)
344K
Typical spread (median absolute deviation)
59K
How far from its usual level
+7.6
Same report last year
232K
History used
1,797 days
2021-11-15: 199K2021-11-30: 232K2021-12-15: 285K2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M
the 30 Nov 2022 report24 earlier reportsnormal: 344K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Dec 2022

Orthofix Medical had 841K shares sold short in the 15 Dec 2022 report, 2.9× the same report last year.

This period
841K (the 15 Dec 2022 report)
Normal report (median of 24 earlier)
367K
Typical spread (median absolute deviation)
74K
How far from its usual level
+4.3
Same report last year
285K
History used
1,812 days
2021-11-30: 232K2021-12-15: 285K2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K
the 15 Dec 2022 report24 earlier reportsnormal: 367K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jan 2023

Orthofix Medical had 961K shares sold short in the 13 Jan 2023 report, 3.3× the same report last year.

This period
961K (the 13 Jan 2023 report)
Normal report (median of 24 earlier)
398K
Typical spread (median absolute deviation)
104K
How far from its usual level
+3.6
Same report last year
295K
History used
1,841 days
2022-01-14: 295K2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K
the 13 Jan 2023 report24 earlier reportsnormal: 398K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Feb 2023

Orthofix Medical had 986K shares sold short in the 31 Jan 2023 report, 3.7× the same report last year.

This period
986K (the 31 Jan 2023 report)
Normal report (median of 24 earlier)
402K
Typical spread (median absolute deviation)
108K
How far from its usual level
+3.6
Same report last year
269K
History used
1,859 days
2022-01-31: 269K2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K
the 31 Jan 2023 report24 earlier reportsnormal: 402K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 28 Feb 2023

Orthofix Medical had 1.0M shares sold short in the 15 Feb 2023 report, 3.5× the same report last year.

This period
1.0M (the 15 Feb 2023 report)
Normal report (median of 24 earlier)
407K
Typical spread (median absolute deviation)
111K
How far from its usual level
+3.7
Same report last year
290K
History used
1,874 days
2022-02-15: 290K2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M
the 15 Feb 2023 report24 earlier reportsnormal: 407K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Mar 2023

Orthofix Medical had 1.0M shares sold short in the 28 Feb 2023 report, 3.5× the same report last year.

This period
1.0M (the 28 Feb 2023 report)
Normal report (median of 24 earlier)
416K
Typical spread (median absolute deviation)
119K
How far from its usual level
+3.6
Same report last year
293K
History used
1,887 days
2022-02-28: 293K2022-03-15: 323K2022-03-31: 293K2022-04-14: 281K2022-04-29: 301K2022-05-13: 345K2022-05-31: 343K2022-06-15: 404K2022-06-30: 399K2022-07-15: 397K2022-07-29: 420K2022-08-15: 411K2022-08-31: 510K2022-09-15: 453K2022-09-30: 389K2022-10-14: 619K2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M
the 28 Feb 2023 report24 earlier reportsnormal: 416K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 12 Nov 2026Insiders record

    Juniper Investment Company, LLC (ten percent owner) and 2 other(s) bought 689,803 shares of OFIX ($5.1M)

  2. 24 Sep 2026Insiders record

    Bartholdson John A. (ten percent owner) and 2 other(s) bought 310,000 shares of OFIX ($2.7M) [amended] (dated 23 Sep 2026)

  3. 11 Jun 2026Filings record

    Director or officer change

  4. 9 May 2026Insiders record

    HENNEMAN JOHN B III (director) bought 5,000 shares of OFIX ($61,300) (dated 8 May 2026)

  5. 8 May 2026Insiders record

    Engine Jet Capital, L.P. (ten percent owner) and 7 other(s) bought 184,896 shares of OFIX ($2.2M) (dated 7 May 2026)

  6. 9 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 9 Apr 2026Filings record

    Director or officer change

  8. 11 Mar 2026Insiders record

    CAPPS VICKIE L (director) bought 5,000 shares of OFIX ($62,324) (dated 10 Mar 2026)

  9. 27 Feb 2026Insiders record

    Ajdler Arnaud (ten percent owner) and 7 other(s) bought 137,858 shares of OFIX ($1.7M) (dated 26 Feb 2026)

  10. 8 Jul 2025Insiders record

    Engine Investments II, LLC (ten percent owner) and 7 other(s) bought 1,250 shares of OFIX ($13,888) (dated 7 Jul 2025)

  11. 6 Jun 2025Insiders record

    Bazaar Alan Lee (director) bought 2,250 shares of OFIX ($24,570) (dated 5 Jun 2025)

  12. 15 May 2025Insiders record

    Engine Investments, LLC (ten percent owner) and 7 other(s) bought 100,000 shares of OFIX [amended] [same transaction as an earlier filing] (dated 14 May 2025)

  13. 13 May 2025Insiders change

    had 3 insiders buy $1.4M of its shares on the open market within 30 days (3 filings).

    Who bought: Bazaar Alan Lee, Calafiore Massimo.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $1.4M
    Window
    13 Apr 2025 to 13 May 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  14. 13 May 2025Insiders record

    Calafiore Massimo (President & CEO) bought 10,000 shares of OFIX ($125,400) (dated 12 May 2025)

  15. 13 May 2025Insiders record

    Bazaar Alan Lee (director) bought 3,990 shares of OFIX ($50,294) (dated 12 May 2025)

  16. 9 May 2025Insiders record

    Engine Lift Capital, LP (ten percent owner) and 4 other(s) bought 100,000 shares of OFIX ($1.2M) (dated 8 May 2025)

  17. 7 Apr 2025Filings record

    A major agreement ended

  18. 12 Mar 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 12 Mar 2025Filings record

    Director or officer change

  20. 7 Mar 2025Insiders record

    Calafiore Massimo (President & CEO) bought 9,914 shares of OFIX ($172,801) (dated 6 Mar 2025)

  21. 8 Nov 2024Filings record

    A major agreement ended

  22. 20 Jun 2024Filings record

    Director or officer change

  23. 12 Apr 2024Filings record

    Director or officer change

  24. 27 Mar 2024Short interest and volume change

    had 3.7M shares sold short in the 15 Mar 2024 report, 3.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.2M.

    See the evidence
    This period
    3.7M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    461K
    How far from its usual level
    +3.7
    Same report last year
    1.1M
    History used
    2,268 days
    2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M2024-03-15: 3.7M
    the 15 Mar 2024 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 12 Mar 2024Short interest and volume change

    had 3.6M shares sold short in the 29 Feb 2024 report, 3.5× the same report last year.

    Same report last year: 1.0M; its normal report is 1.1M.

    See the evidence
    This period
    3.6M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    381K
    How far from its usual level
    +4.3
    Same report last year
    1.0M
    History used
    2,253 days
    2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M
    the 29 Feb 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 12 Mar 2024Financials change

    reported revenue of $200.4M for the quarter ended 31 Dec 2023, 1.6× the same quarter last year.

    Same quarter last year: $122.2M; its normal quarter is $123.6M.

    See the evidence
    This period
    $200.4M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $123.6M
    Typical spread (median absolute deviation)
    $13.4M
    How far from its usual level
    +3.9
    Same quarter last year
    $122.2M
    History used
    5,023 days
    2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M2023-12-31: $200.4M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $123.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  27. 12 Mar 2024Financials change

    spent $14.6M on capital projects in the quarter ended 31 Dec 2023, 2.8× the same quarter last year.

    Same quarter last year: $5.2M; its normal quarter is $6.0M.

    See the evidence
    This period
    $14.6M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $6.0M
    Typical spread (median absolute deviation)
    $798K
    How far from its usual level
    +7.3
    Same quarter last year
    $5.2M
    History used
    4,840 days
    2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M2023-12-31: $14.6M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $6.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  28. 28 Feb 2024Short interest and volume change

    had 3.3M shares sold short in the 15 Feb 2024 report, 3.3× the same report last year.

    Same report last year: 1.0M; its normal report is 1.1M.

    See the evidence
    This period
    3.3M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    331K
    How far from its usual level
    +4.5
    Same report last year
    1.0M
    History used
    2,239 days
    2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M
    the 15 Feb 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 10 Feb 2024Short interest and volume change

    had 2.7M shares sold short in the 31 Jan 2024 report, 2.8× the same report last year.

    Same report last year: 986K; its normal report is 1.1M.

    See the evidence
    This period
    2.7M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    238K
    How far from its usual level
    +4.6
    Same report last year
    986K
    History used
    2,224 days
    2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M
    the 31 Jan 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 25 Jan 2024Short interest and volume change

    had 2.9M shares sold short in the 12 Jan 2024 report, 3.1× the same report last year.

    Same report last year: 961K; its normal report is 1.1M.

    See the evidence
    This period
    2.9M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    184K
    How far from its usual level
    +6.9
    Same report last year
    961K
    History used
    2,205 days
    2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M
    the 12 Jan 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 17 Jan 2024Filings record

    Director or officer change

  32. 11 Jan 2024Short interest and volume change

    had 2.9M shares sold short in the 29 Dec 2023 report, 4.3× the same report last year.

    Same report last year: 670K; its normal report is 1.0M.

    See the evidence
    This period
    2.9M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    196K
    How far from its usual level
    +6.4
    Same report last year
    670K
    History used
    2,191 days
    2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M
    the 29 Dec 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 9 Jan 2024Filings record

    Director or officer change

  34. 28 Dec 2023Short interest and volume change

    had 4.7M shares sold short in the 15 Dec 2023 report, 5.6× the same report last year.

    Same report last year: 841K; its normal report is 1.0M.

    See the evidence
    This period
    4.7M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    177K
    How far from its usual level
    +14.1
    Same report last year
    841K
    History used
    2,177 days
    2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M
    the 15 Dec 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 15 Dec 2023Filings record

    Director or officer change

  36. 12 Dec 2023Short interest and volume change

    had 3.6M shares sold short in the 30 Nov 2023 report, 3.6× the same report last year.

    Same report last year: 1.0M; its normal report is 1.0M.

    See the evidence
    This period
    3.6M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    169K
    How far from its usual level
    +10.4
    Same report last year
    1.0M
    History used
    2,162 days
    2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M
    the 30 Nov 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 1 Dec 2023Filings record

    Director or officer change

  38. 28 Nov 2023Short interest and volume change

    had 3.3M shares sold short in the 15 Nov 2023 report, 3.3× the same report last year.

    Same report last year: 1.0M; its normal report is 1.0M.

    See the evidence
    This period
    3.3M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    131K
    How far from its usual level
    +12.0
    Same report last year
    1.0M
    History used
    2,147 days
    2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M
    the 15 Nov 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  39. 14 Nov 2023several at once

    spent $21.9M on capital projects in the quarter ended 30 Sep 2023, 4.3× the same quarter last year, while it had 4.7M shares sold short in the 15 Dec 2023 report, 5.6× the same report last year. Two unrelated kinds of activity within 140 days.

    See the evidence (14 changes)

    Financials: Quarterly capital spending jump became public on 14 Nov 2023

    Orthofix Medical spent $21.9M on capital projects in the quarter ended 30 Sep 2023, 4.3× the same quarter last year.

    This period
    $21.9M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $5.5M
    Typical spread (median absolute deviation)
    $549K
    How far from its usual level
    +16.4
    Same quarter last year
    $5.1M
    History used
    4,748 days
    2021-09-30: $2.5M2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $5.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Financials: Quarterly revenue change became public on 14 Nov 2023

    Orthofix Medical reported revenue of $184.0M for the quarter ended 30 Sep 2023, 1.6× the same quarter last year.

    This period
    $184.0M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $120.1M
    Typical spread (median absolute deviation)
    $6.9M
    How far from its usual level
    +5.3
    Same quarter last year
    $114.0M
    History used
    4,931 days
    2021-09-30: $112.4M2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $120.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 10 Nov 2023

    Orthofix Medical had 3.0M shares sold short in the 31 Oct 2023 report, 3.0× the same report last year.

    This period
    3.0M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +14.3
    Same report last year
    981K
    History used
    2,132 days
    2022-10-31: 981K2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M
    the 31 Oct 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 Nov 2023

    Orthofix Medical had 3.3M shares sold short in the 15 Nov 2023 report, 3.3× the same report last year.

    This period
    3.3M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    131K
    How far from its usual level
    +12.0
    Same report last year
    1.0M
    History used
    2,147 days
    2022-11-15: 1.0M2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M
    the 15 Nov 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Dec 2023

    Orthofix Medical had 3.6M shares sold short in the 30 Nov 2023 report, 3.6× the same report last year.

    This period
    3.6M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    169K
    How far from its usual level
    +10.4
    Same report last year
    1.0M
    History used
    2,162 days
    2022-11-30: 1.0M2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M
    the 30 Nov 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 Dec 2023

    Orthofix Medical had 4.7M shares sold short in the 15 Dec 2023 report, 5.6× the same report last year.

    This period
    4.7M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    177K
    How far from its usual level
    +14.1
    Same report last year
    841K
    History used
    2,177 days
    2022-12-15: 841K2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M
    the 15 Dec 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 11 Jan 2024

    Orthofix Medical had 2.9M shares sold short in the 29 Dec 2023 report, 4.3× the same report last year.

    This period
    2.9M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    196K
    How far from its usual level
    +6.4
    Same report last year
    670K
    History used
    2,191 days
    2022-12-30: 670K2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M
    the 29 Dec 2023 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Jan 2024

    Orthofix Medical had 2.9M shares sold short in the 12 Jan 2024 report, 3.1× the same report last year.

    This period
    2.9M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    184K
    How far from its usual level
    +6.9
    Same report last year
    961K
    History used
    2,205 days
    2023-01-13: 961K2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M
    the 12 Jan 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Feb 2024

    Orthofix Medical had 2.7M shares sold short in the 31 Jan 2024 report, 2.8× the same report last year.

    This period
    2.7M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    238K
    How far from its usual level
    +4.6
    Same report last year
    986K
    History used
    2,224 days
    2023-01-31: 986K2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M
    the 31 Jan 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 28 Feb 2024

    Orthofix Medical had 3.3M shares sold short in the 15 Feb 2024 report, 3.3× the same report last year.

    This period
    3.3M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    331K
    How far from its usual level
    +4.5
    Same report last year
    1.0M
    History used
    2,239 days
    2023-02-15: 1.0M2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M
    the 15 Feb 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly capital spending jump became public on 12 Mar 2024

    Orthofix Medical spent $14.6M on capital projects in the quarter ended 31 Dec 2023, 2.8× the same quarter last year.

    This period
    $14.6M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $6.0M
    Typical spread (median absolute deviation)
    $798K
    How far from its usual level
    +7.3
    Same quarter last year
    $5.2M
    History used
    4,840 days
    2021-12-31: $6.2M2022-03-31: $5.3M2022-06-30: $5.7M2022-09-30: $5.1M2022-12-31: $5.2M2023-03-31: $11.5M2023-06-30: $12.4M2023-09-30: $21.9M2023-12-31: $14.6M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $6.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Financials: Quarterly revenue change became public on 12 Mar 2024

    Orthofix Medical reported revenue of $200.4M for the quarter ended 31 Dec 2023, 1.6× the same quarter last year.

    This period
    $200.4M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $123.6M
    Typical spread (median absolute deviation)
    $13.4M
    How far from its usual level
    +3.9
    Same quarter last year
    $122.2M
    History used
    5,023 days
    2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M2023-12-31: $200.4M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $123.6M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 12 Mar 2024

    Orthofix Medical had 3.6M shares sold short in the 29 Feb 2024 report, 3.5× the same report last year.

    This period
    3.6M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.1M
    Typical spread (median absolute deviation)
    381K
    How far from its usual level
    +4.3
    Same report last year
    1.0M
    History used
    2,253 days
    2023-02-28: 1.0M2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M
    the 29 Feb 2024 report24 earlier reportsnormal: 1.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 27 Mar 2024

    Orthofix Medical had 3.7M shares sold short in the 15 Mar 2024 report, 3.4× the same report last year.

    This period
    3.7M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    461K
    How far from its usual level
    +3.7
    Same report last year
    1.1M
    History used
    2,268 days
    2023-03-15: 1.1M2023-03-31: 1.1M2023-04-14: 1.0M2023-04-28: 1.0M2023-05-15: 1.1M2023-05-31: 1.2M2023-06-15: 1.0M2023-06-30: 803K2023-07-14: 743K2023-07-31: 707K2023-08-15: 688K2023-08-31: 647K2023-09-15: 1.2M2023-09-29: 1.3M2023-10-13: 1.5M2023-10-31: 3.0M2023-11-15: 3.3M2023-11-30: 3.6M2023-12-15: 4.7M2023-12-29: 2.9M2024-01-12: 2.9M2024-01-31: 2.7M2024-02-15: 3.3M2024-02-29: 3.6M2024-03-15: 3.7M
    the 15 Mar 2024 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  40. 14 Nov 2023Financials change

    reported revenue of $184.0M for the quarter ended 30 Sep 2023, 1.6× the same quarter last year.

    Same quarter last year: $114.0M; its normal quarter is $120.1M.

    See the evidence
    This period
    $184.0M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $120.1M
    Typical spread (median absolute deviation)
    $6.9M
    How far from its usual level
    +5.3
    Same quarter last year
    $114.0M
    History used
    4,931 days
    2021-09-30: $112.4M2021-12-31: $125.1M2022-03-31: $106.4M2022-06-30: $118.1M2022-09-30: $114.0M2022-12-31: $122.2M2023-03-31: $175.2M2023-06-30: $187.0M2023-09-30: $184.0M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $120.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

Showing the newest 40 of 109 entries; narrow the window or the kind of data to see older ones.

Not listed: 192 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000884624
Ticker
OFIX
Domain
orthofix.com
Employer name
Orthofix US LLC (1 unverified)
Fein
75-2608036 (1 unverified)
Hq location
TX|LEWISVILLE|75056 (1 unverified)
Name
7D Surgical ULC, Company, Implantes y Sistemas Medicos, Inc, IosTis, Inc and 15 more
  • DOL H-1B labor condition applications and PERM certifications2 data points10 Aug 2026 to 10 Aug 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)166 records12 Jan 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1162 data points31 Dec 2008 to 5 Nov 2026
  • SEC Form 4 insider transactions93 records, 296 data points18 Apr 2016 to 12 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026